BackSolid Biosciences Overview

Solid Biosciences Total Assets

Track Solid Biosciences's total assets ($420M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$422.89M
22.97% YoYΔ $78.99M vs prior year quarter

Peer average

Loading

Solid Biosciences Total Assets History

Loading

Solid Biosciences vs. peers: Total Assets Comparison

Loading

Solid Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Solid Biosciences (SLDB) FAQ

The latest total assets for SLDB is $420M as of March 2026. That compares with $340M in the prior-year period — up 23.0% year over year. Investors often review this figure alongside Solid Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SLDB's total assets moved from $340M to $420M — a 23.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Solid Biosciences's operating scale or balance-sheet position.

A total assets figure of $420M for SLDB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLDB's total assets ($420M), review year-over-year change from $340M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Solid Biosciences's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.